Related Experiment Video

Updated: Aug 15, 2026

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb (BCG lux/M.Tb lux)
08:10

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb (BCG lux/M.Tb lux)

Published on: September 14, 2011

Ethnic differences in the rates of BCG vaccination

S A Deshpande1

  • 1Royal Shrewsbury Hospital, Mytton Oak Road, Shrewsbury SY3 8XQ, UK. deshpande@which.net

Archives of Disease in Childhood
|January 8, 2004
PubMed

Insights

A review of the neonatal BCG vaccination program found only 51% of eligible infants received the vaccine. Infants of Indian subcontinent origin were more likely to be vaccinated, highlighting a need for improved awareness and simpler criteria for all infants.

Area of Science:

  • Public Health
  • Immunization Programs
  • Pediatrics

Background:

  • The neonatal Bacillus Calmette-Guérin (BCG) immunization program aims to protect infants from tuberculosis.
  • Audits are crucial for assessing the effectiveness and reach of public health interventions like vaccination programs.

Purpose of the Study:

  • To audit the selective neonatal BCG immunization program's uptake rates.
  • To identify disparities in BCG vaccination coverage among different infant populations.
  • To provide recommendations for improving BCG vaccination rates.

Main Methods:

  • An audit was conducted on the selective neonatal BCG immunization program.
  • Vaccination data was collected and analyzed for eligible infants.
  • Infant demographics, specifically origin, were compared regarding vaccination status.

Main Results:

  • Only 51% of eligible infants received the neonatal BCG vaccination.
  • Infants of Indian subcontinent origin (ISC) had a significantly higher vaccination rate (70%) compared to non-ISC infants (29%).
  • Significant disparities in BCG vaccination uptake were observed based on infant origin.

Conclusions:

  • The current selective neonatal BCG immunization program has suboptimal uptake.
  • Targeted interventions are needed to increase BCG vaccination rates among non-ISC infants.
  • Simplifying eligibility criteria and increasing awareness are recommended to improve overall BCG coverage.

More Related Videos

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Related Concept Videos

Probability Laws01:49

Probability Laws

Overview
Vaccinations01:51

Vaccinations

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...